(22.09.2021)

A study led by Pfizer Inc. and BioNTech SE evaluating their Covid-19 vaccine in expectant mothers has been complicated by slow enrollment, researchers say, delaying results that could help inform physicians about how the shots affect pregnant women and their babies.

Pfizer closed enrollment at many U.S. sites this summer, after fewer than expected numbers of subjects entered the study, researchers say